Long-term prognosis in patients undergoing redo-isolated aortic valve replacement - supplementary materials

<b>Aim: </b>To evaluate clinical outcomes after redo aortic valve replacement (AVR) with sutured valves, versus valve-in-valve transcatheter aortic valve replacement (ViV-TAVR), versus sutureless valves. <b>Methods: </b>We identified 113 consecutive patients undergoing redo AVR with either ViV-TAVR, redo-sutured and redosutureless valves between August 2010 to March 2020. Heart-team made the decision whether patient should undergo redo-sutureless versus ViV-TAVR, versus redo-sutured AVR. <b>Results: </b>Preoperatively, redosutured (n <b>= </b>57), ViV-TAVR (n <b>= </b>31) and redo-sutureless (n <b>= </b>25) patients were compared. Postoperatively, after propensity-adjustment analysis, the redo SAVR group had a higher incidence of new postoperative atrial fibrillation (POAF; p <b>= </b>0.04) compared with redo-sutureless group. Follow-up outcomes analysis did not show differences among groups. <b>Conclusion: </b>Patients undergoing redo-sutureless AVR experienced a higher incidence of POAF compared with patients undergoing redo-sutured.